Logo image
IRO Home Research units Researcher Profiles
Sign in
LDL reduction: how low should we go and is it safe?
Journal article

LDL reduction: how low should we go and is it safe?

Jennifer G Robinson
Current cardiology reports, Vol.10(6), pp.481-487
11/2008
DOI: 10.1007/s11886-008-0076-3
PMID: 18950559

View Online

Abstract

Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage Humans Ezetimibe Allylamine - therapeutic use Allylamine - adverse effects Fenofibrate - therapeutic use Niacin - therapeutic use Cholesterol, LDL - blood Muscular Diseases - chemically induced Drug Therapy, Combination Colesevelam Hydrochloride Stroke - prevention & control Hyperlipidemias - drug therapy Risk Factors Allylamine - analogs & derivatives Azetidines - adverse effects Coronary Artery Disease - prevention & control Cholesterol, LDL - drug effects Coronary Artery Disease - drug therapy Hyperlipidemias - prevention & control Anticholesteremic Agents - adverse effects Disease Progression Anticholesteremic Agents - therapeutic use Azetidines - therapeutic use Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Hypolipidemic Agents - therapeutic use

Details

Metrics

24 Record Views
Logo image